AI-powered blood test detects Parkinson's disease years before symptoms appear, revolutionizing early diagnosis and treatment ...

A new study by researchers at Ireland's Maynooth University, based on patient data gathered by the US-based Michael J. Fox Foundation, found that an overwhelming 84% of patients with Parkinson's ...

This has the capacity to connect generations in a caring, helping way, which you can’t do artificially. I have to admit, I did not foresee that in this regard.” And with that, Española Glove Works was ...

Inhibikase Therapeutics announced disappointing results from a Phase 2 trial for its Parkinson’s disease drug, risvodetinib, and will now pause its development.

Jupiter is actively exploring additional strategic partnerships to expand JOTROL's application across other neuroinflammatory and metabolic disorders, including Alzheimer's disease and longevity ...

Inhibikase’s setback continues biopharma’s losing streak against Parkinson’s, marked by several clinical failures and ...

Sleep problems are very common in people with Parkinson’s disease and are associated with poorer quality of life in patients, ...

Hearing loss may raise Parkinson’s risk by 57% per 10-decibel drop. Study calls for integrated care strategies.

Fighting Back: Rock Steady Boxing West Michigan helps Parkinson's patients regain control Kournikova, who stays mostly out of ...

Parkinson's disease affects not only muscle movement but also the mental health of those diagnosed. While there is no cure, ...

ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD), a biopharmaceutical company with a market capitalization of $3.06 billion, focuses on developing and commercializing innovative medicines to address unmet ...